Applied DNA to Host Fourth Quarter and Fiscal 2017 Financial Results Conference Call on Thursday, December 28, 2017 at 4:30 PM ET

December 26, 2017

STONY BROOK, N.Y.–(BUSINESS WIRE)–Applied
DNA Sciences, Inc. (NASDAQ: APDN), announced today it plans to
release results for the fourth quarter and fiscal 2017 ended September
30, 2017 after market close on Thursday, December 28, 2017. In
conjunction with the release, the Company has scheduled a conference
call at 4:30 p.m. Eastern Time that will also be broadcast live over the
internet.

What: Applied DNA’s Fourth Quarter and Fiscal 2017 Financial
Results Conference Call

When: Thursday, December 28, 2017, at 4:30 p.m. Eastern Time

Where: Via phone by dialing +1 844-887-9402 or +1 412-317-6798
and ask for the Applied DNA call; via webcast.

A telephonic replay of the conference call will be available for one day
and may be accessed by calling +1 877-344-7529 or +1 412-317-0088 with
the passcode 10113295. The webcast
will be archived in the Investor
Relations section of the company’s website.

About Applied DNA Sciences

Applied DNA is a provider of molecular technologies that enable supply
chain security, anti-counterfeiting and anti-theft technology, product
genotyping and DNA mass production for diagnostics and therapeutics.

We make life real and safe by providing innovative, molecular-based
technology solutions and services that can help protect products,
brands, entire supply chains, and intellectual property of companies,
governments and consumers from theft, counterfeiting, fraud and
diversion. The proprietary DNA-based CertainT® platform can be used to
identify, tag, test, and track products, to help assure authenticity,
origin, traceability, sustainability and quality of products.

SigNature® DNA describes the core technology ingredient that is at the
heart of a family of uncopyable, security and authentication solutions
such as SigNature®T and fiberTyping®, targeted towards textiles and
apparel, BackTrac® and DNAnet®, for anti-theft and loss prevention, and
digitalDNA®, providing powerful track-and-trace. All provide a forensic
chain of evidence, and can be used to prosecute perpetrators. Applied
DNA Sciences is also engaged in the large-scale production of specific
DNA sequences using the polymerase chain reaction.

Visit adnas.com for
more information. Follow us on Twitter and LinkedIn.
Join our mailing
list.

Forward Looking Statements

The statements made by APDN in this press release may be
“forward-looking” in nature within the meaning of the Private Securities
Litigation Act of 1995. Forward-looking statements describe APDN’s
future plans, projections, strategies and expectations, and are based on
assumptions and involve a number of risks and uncertainties, many of
which are beyond the control of APDN. Actual results could differ
materially from those projected due to our short operating history,
limited financial resources, limited market acceptance, market
competition and various other factors detailed from time to time in
APDN’s SEC reports and filings, including our Annual Report on Form 10-K
filed on December 6, 2016, and our subsequent quarterly reports on Form
10-Q filed on February 9, 2017, May 11, 2017 and August 10, 2017, which
are available at www.sec.gov.
APDN undertakes no obligation to update publicly any forward-looking
statements to reflect new information, events or circumstances after the
date hereof to reflect the occurrence of unanticipated events, unless
otherwise required by law.